Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
NCT00062205
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma
Interventions
DRUG:
imatinib mesylate
Sponsor
City of Hope Medical Center
Collaborators
[object Object]